Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 118948
Published online Sep 15, 2026. doi: 10.4251/wjgo.118948
Published online Sep 15, 2026. doi: 10.4251/wjgo.118948
Table 1 Baseline status of enrolled cases
| TH-HebMU cohort-1 | TH-HebMU cohort-2 | TH-HebMU cohort-3 | |||||||
| Non-HCC (n = 131) | HCC (n = 68) | P value | Non-HCC (n = 135) | HCC (n = 66) | P value | Non-HCC (n = 5) | HCC (n = 5) | P value | |
| Sex | 0.002b | 0.142 | 1.000 | ||||||
| Male | 85 | 58 | 93 | 52 | 4 | 4 | |||
| Female | 46 | 10 | 42 | 14 | 1 | 1 | |||
| Age | 43.13 ± 13.671 | 55.79 ± 10.74 | < 0.001c | 50.81 ± 11.31 | 59.98 ± 12.65 | < 0.001c | 47.00 ± 11.55 | 58.20 ± 9.07 | > 0.05 |
| miR-200b-3p | 28.42 ± 23.21 | 61.75 ± 63.99 | < 0.001c | -9.24 ± 1.03 | -8.51 ± 0.78 | < 0.001c | 33369 ± 12333 | 15753 ± 7165 | < 0.05a |
| miR-215-5p | 942.51 ± 1422.19 | 3927.90 ± 6286.45 | < 0.001c | -8.46 ± 0.83 | -7.53 ± 0.78 | < 0.001c | 156.1 ± 103.5 | 754.8 ± 247.7 | < 0.01b |
| miR-335-5p | 35.96 ± 22.04 | 53.92 ± 33.97 | < 0.001c | -9.41 ± 0.72 | -8.78 ± 0.81 | < 0.001c | 35 ± 23.7 | 238.3 ± 52.6 | < 0.01b |
| miR-378a-3p | 818.66 ± 305.82 | 1063.99 ± 376.92 | < 0.001c | -7.15 ± 0.84 | -6.27 ± 0.95 | < 0.001c | 79340 ± 15325 | 66567 ± 27158 | > 0.05 |
| miR-452-5p | 9.55 ± 10.45 | 24.62 ± 48.77 | < 0.001c | -9.98 ± 1.07 | -8.90 ± 1.27 | < 0.001c | 268.7 ± 184.4 | 1087 ± 1108 | > 0.05 |
| miR-501-3p | 263.94 ± 123.31 | 410.85 ± 240.83 | < 0.001c | -8.64 ± 0.79 | -7.79 ± 0.82 | < 0.001c | 3226 ± 1680 | 1196 ± 199.7 | < 0.05a |
- Citation: Sun XY, Fu N, Zhao DD, Wang ZL, Cao L, Qiu JL, Li Y, Gao W, Duan JL, Li L, Nan YM. Integrated diagnostic model based on serum exosomal microRNAs and functional mechanism of miR-200b-3p in hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(9): 118948
- URL: https://www.wjgnet.com/1948-5204/full/v18/i9/118948.htm
- DOI: https://dx.doi.org/10.4251/wjgo.118948